23. Drugs Used In Neurological Disorders Flashcards

1
Q

What is meant by idiopathic Parkinson’s disease (IPD)?

A
  • cause is unknown
  • also known as ‘parkinsons’
  • most common type of Parkinsonism
  • neurodegenerative disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the clinical features of Parkinsonism?

Mnemonic: TRAP (patients trapped in their poorly mobile body)

A

1) Tremor: pill rolling, resting tremor. Abolished by movement. Usually unilateral (later can be bilateral)
2) Rigidity: cog-wheel rigidity (other form is lead pipe)
3) Akinesia/bradykinesia: slowing down and loss of spontaneous automatic movements. Hypomimia, micrographia, hypophonia, drooling
4: Postural instability: impaired balance so patients fall over easily.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the non motor manifestations of parkinsons

A
  • mood changes: depression,anxiety
  • pain
  • frequency of micturition
  • sleep disorders: REM sleep disorder, violent + vidid dreams
  • sweating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the prognosis of PD?

A
  • drugs can help but the degeneration of the brain will continue
  • dyskinesia
  • falls (shouldn’t fall in early parkinsons)
  • hallucinations
  • swallowing difficulty
  • somnolence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name some other causes of Parkinsonism (i.e. differentials for IPD)

Mnemonic: VODKA

A

V: Vascular events e.g. stroke, MI
O: orthostatic hypotension and atonic bladder (look for multi system organ failure)
D: dementia and vertical gaze paralysis (consider supranuclear palsy)
K: Kayser-Fleisher ring (consider Wilson’s disease)
A: apraxia gait (communicating hydrocephalus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the parkinsons plus disorders?

A
  • Respond poorly to the standard treatments for Parkinson disease
  • Often have a poor prognosis with faster rate of progression and death
    5 Separate syndromes:
    1. Multiple system atrophy (MSA)
    2. Progressive supranuclear palsy (PSP)
    3. Parkinsonism-dementia-amyotrophic lateral sclerosis complex
    4. Corticobasal ganglionic degeneration (CBD)
    5. Dementia with Lewy bodies (DLB)
    Clinical Features:
  • Early onset of dementia
  • Early onset of postural instability
  • Early onset of hallucinations or psychosis
  • Early autonomic symptoms: postural hypotension and urinary incontinence
  • Ocular signs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a DAT scan?

A
  • labelled tracer looking at pre synaptic uptake of dopamine
  • if dopaminergic neurones disappear dont see as much

This is not a test for Parkinson’s however. Though it is abnormal in parkinsons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the pathology of IPD?

A
  • neurodegeneration
  • reduced dopamine
  • Lewy bodies (synucleinopathy)
  • loss of pigment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Normally, dopamine has an inhibitory effect on ACh. What happens if you lose dopamine?

A
  • more ACh activity
  • ACh will then stimulate GABA which is inhibitory
  • this causes slowness of movement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is dopamine synthesised?

A
  • synthesised from L-Tyrosine
  • then L-DOPA
  • then dopamine
  • then noradrenaline
  • then adrenaline

The enzyme that converts L-DOPA to dopamine is DOPA decarboxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is dopamine degraded?

A
  • dopamine is eventually degraded to homovanillic acid
    The major enzymes involved are:
  • Monoamine oxidase and aldehyde dehydrogenase
    *Catechol-O-methyl transferase
    The 2 intermediates are:
    3-methoxytyramine
    3,4 dihydrophenol acetic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name the drug classes which can be used in IPD?

A
  1. Levodopa (L-Dopa)
  2. Dopamine receptor agonists
  3. MAO type B inhibitors
  4. COMT inhibitors
  5. Anticholinergics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does L-dopa work?

A
  • taken up by dopaminergic neurones into the substantia nigra
  • converted into dopamine
  • this is why if there’s no dopaminergic neurones left then it wont be able to work
  • so as disease progresses the treatment doesn’t work as well
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What food should be avoided when taking L-Dopa?

A
  • protein rich e.g. steaks
  • because it can be antagonised by amino acids
  • in competition with vitamin B6
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Discuss the pharmacokinetics of L-Dopa focussing on half life and bioavailability

A
  • taken orally
  • short half life 2hrs
  • 90% inactivated in intestinal wall
  • 9% that has been absorbed is converted to D2 in peripheral tissues
  • so less than 1% enters the CNS

Need strategies to preserve it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What do we give L-DOPA in combination with? Give 2 examples

A

A peripheral DOPA decarboxylase inhibitor

Co-careldopa- Sinemet
Co-beneldopa - Madopar

This allows us to reduce the dose, so less side effects and increased L-DOPA reaching the brain

17
Q

What are the side effects of L-DOPA?

A
  • nausea and vomiting (can give domperidone)
  • hypotension
  • tachycardia
  • hallucinations/delusions and paranoia
18
Q

What are the long term motor complications of giving the drug L-DOPA?

A
  • on/off, wearing off
  • freezing
  • dystopia
  • dyskinesia
19
Q

What are the potential interactions of L-DOPA with other drugs?

A
  • Pyridoxine (vitamin B6) increases the peripheral breakdown of L-DOPA
  • MAOIs: risk of hypertensive crisis

Many antipsychotics block dopamine receptors resulting in Parkinsonism as a side effect so check their other drugs.

20
Q

Name some dopamine receptor agonist (both ergot and non ergot)

A

Ergot: bromocriptine, cabergoline

Non-ergot: Ropinirole

Patch: rotigotine - good for those that can’t take it orally

In patients with severe motor fluctuations can give apomorphine as rescue medication.

21
Q

What are the advantages of dopamine receptor agonists?

A
  • direct acting and don’t require dopaminergic neurones to be in place
  • less motor complications
  • possible neuroprotection
22
Q

What are the disadvantages of dopamine receptor agonists?

A
  • less efficacy then L-dopa
  • impulse control disorders: hyper sexuality, gambling, compulsive shopping
  • more psychiatric side effects e.g. hallucinations, confusion
  • nausea, hypotension
23
Q

How do MAOI work?

A
  • normally monoamine oxidase metabolises dopamine
  • if you inhibit it you will enhance dopamine
  • can be used alone or to prolong action of L-DOPA
24
Q

Give 2 examples of MAOI’s?

A
  • selegiline

- rasagiline

25
Q

How do COMT inhibitors work?

A
  • no therapeutic effect alone
  • given in combination with L-DOPA
  • this prevents peripheral breakdown of L-DOPA to 3-0-methyldopa
  • this allows more L DOPA to get into the CNS
  • because normally 3-0 methyldopa competes with L-DOPA for entry into CNS
26
Q

Give 2 examples fo COMT Inhibitors.

A

Entacapone

Tolcapone

27
Q

What are anticholinergics useful for treating? Examples

A
  • tremor predominant parkinsons
  • doesn’t treat bradykinesia
  • procyclidine
  • Orphenadrine

Will get usual anticholinergics side effects

28
Q

What is amantadine?

A
  • thought too enhance dopamine release but mechanism uncertain
  • poorly effective so hardly used
  • used in fatigue and MS
29
Q

In which parkinsons patients can we use surgery?

A
  • only dopamine responsive patients
  • must have had side effects to drugs
  • no psychiatric illness, must be screened as there can be depression post surgery
30
Q

What do we target in surgery for parkinsons?

A

Thalamus: for tremor (T for T)
Globus pallidus interna for dyskinesias

Deep brain stimulation: subthalamic nucleus

31
Q

What is myasthenia gravis?

A
  • autoimmune disease
  • antibodies are produced to the ACh receptors at the NMJ
  • cant get ACh in which will lead to fluctuating, faiguable weakness at the skeletal muscles
32
Q

Name the signs seen in myasthenia gravis

A
  • Extraocular muscles: ptosis and diplopia
  • Bulbar involvement - dysphagia, dysphonia, dysarthria
  • Limb weakness
  • respiratory muscle involvement

May see frontalis overactivity and the eyelid may come down over the pupil which can only happen in MG cannot do voluntarily

33
Q

What drugs actually make myasthenia gravis worse?

A

This drugs which affect neuromuscular transmission:

E.g. magnesium
Succinylcholine
Beta blockers, CCBs
ACE inhibitors 
Aminoglycosides
34
Q

What classes of drugs can be used to treat myasthenia gravis?

A
  • Acetylcholinesterase inhibitors e.g. pyridostigmine and neostigmine to treat symptoms
  • corticosteroids e.g. azathioprine decrease immune response
  • IV immunoglobulin : for acute decline or crisis
  • plasmapheresis: removes AChR antibodies (short term improvement)
35
Q

What are the antimuscarinic side effects of pyridostigmine and neostigmine?

Mnemonic: SSLUDGE

A

Drugs like pyridostigmine are very effective as they prevent breakdown of ACh in NMJ so ACh is more likely to engage with the remaining receptors and so patients may take too much of it and it can lead to cholinergic crisis whereby we get anti-muscarinic side effects: miosis and SSLUDGE:

S: salivation 
S: sweating 
L: lacrimation
U: urinary incontinence 
D: diarrhoea 
G: GI upset and hyeprmotility 
E: Emesis
36
Q

What directions must be given regarding acetylcholinesterase inhibitors e.g. pyridostigmine?

A
  • 30-40 mins before meals
  • require close monitoring if bulbar symptoms
  • before giving give 1/10th dose to see if they have a cardiac reaction